186 related articles for article (PubMed ID: 10583886)
1. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia.
Sainio S; Teramo K; Kekomäki R
Transfus Med; 1999 Dec; 9(4):321-30. PubMed ID: 10583886
[TBL] [Abstract][Full Text] [Related]
2. Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies.
Murphy MF; Waters AH; Doughty HA; Hambley H; Mibashan RS; Nicolaides K; Rodeck CH
Transfus Med; 1994 Dec; 4(4):281-92. PubMed ID: 7889140
[TBL] [Abstract][Full Text] [Related]
3. Neonatal alloimmune thrombocytopenia: antenatal management.
Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
[TBL] [Abstract][Full Text] [Related]
4. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families.
Kanhai HH; Porcelijn L; van Zoeren D; Klumper F; Viëtor H; Meerman RH; Brand A
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):67-73. PubMed ID: 8886684
[TBL] [Abstract][Full Text] [Related]
5. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions.
Murphy MF; Metcalfe P; Waters AH; Ord J; Hambley H; Nicolaides K
Blood; 1993 Apr; 81(8):2174-9. PubMed ID: 8471776
[TBL] [Abstract][Full Text] [Related]
6. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
[TBL] [Abstract][Full Text] [Related]
7. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.
Ghevaert C; Campbell K; Walton J; Smith GA; Allen D; Williamson LM; Ouwehand WH; Ranasinghe E
Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957
[TBL] [Abstract][Full Text] [Related]
8. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia.
Birchall JE; Murphy MF; Kaplan C; Kroll H;
Br J Haematol; 2003 Jul; 122(2):275-88. PubMed ID: 12846898
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage].
Radder CM; Kanhai HH; de Beaufort AJ; Klumper FJ; Brand A
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2015-8. PubMed ID: 11072521
[TBL] [Abstract][Full Text] [Related]
10. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
Berkowitz RL; Lesser ML; McFarland JG; Wissert M; Primiani A; Hung C; Bussel JB
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):249-55. PubMed ID: 17666597
[TBL] [Abstract][Full Text] [Related]
11. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A
J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118
[TBL] [Abstract][Full Text] [Related]
12. [Intrauterine transfusion in fetal alloimmunothrombocytopenia: comparison of maternal and fetal weight-adjusted IgG therapy with exclusive fetal thrombocyte transfusion].
Giers G; Kroll H; Hoch J; Bald R; Bauer H; Kiefel V; Hansmann M; Hanfland P; Mueller-Eckhardt C; Scharf RE
Beitr Infusionsther Transfusionsmed; 1997; 34():276-80. PubMed ID: 9417349
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal thrombopoietin plasma concentrations in fetuses with alloimmune thrombocytopenia treated with intrauterine PLT transfusions.
Cremer M; Dame C; Schaeffer HJ; Giers G; Bartmann P; Bald R
Transfusion; 2003 Sep; 43(9):1216-22. PubMed ID: 12919423
[TBL] [Abstract][Full Text] [Related]
14. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
[TBL] [Abstract][Full Text] [Related]
15. Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period.
Tiblad E; Olsson I; Petersson K; Shanwell A; Winiarski J; Wolff K; Westgren M
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):803-6. PubMed ID: 12911440
[TBL] [Abstract][Full Text] [Related]
16. Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility.
Gaddipati S; Berkowitz RL; Lembet AA; Lapinski R; McFarland JG; Bussel JB
Am J Obstet Gynecol; 2001 Oct; 185(4):976-80. PubMed ID: 11641688
[TBL] [Abstract][Full Text] [Related]
17. Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia.
Kroll H; Kiefel V; Giers G; Bald R; Hoch J; Hanfland P; Hansmann M; Mueller-Eckhardt C
Transfus Med; 1994 Dec; 4(4):293-6. PubMed ID: 7889141
[TBL] [Abstract][Full Text] [Related]
18. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
19. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis.
Spencer JA; Burrows RF
Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):45-55. PubMed ID: 11284646
[TBL] [Abstract][Full Text] [Related]
20. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period].
Deruelle P; Wibaut B; Manessier L; Subtil D; Vaast P; Puech F; Valat AS
Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
